Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
209,618,986
-
Total 13F shares
-
68,664,954
-
Share change
-
+1,686,738
-
Total reported value
-
$381,777,979
-
Put/Call ratio
-
32%
-
Price per share
-
$5.56
-
Number of holders
-
109
-
Value change
-
+$5,091,371
-
Number of buys
-
57
-
Number of sells
-
43
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2017
As of 30 Jun 2017 BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) had 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 68,664,954 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, RTW INVESTMENTS, LP, FMR LLC, and VHCP Management II, LLC.
This table shows 111 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.